Hikma Pharmaceuticals Plc Block listing Interim Review (8056A)
October 01 2020 - 6:01AM
UK Regulatory
TIDMHIK
RNS Number : 8056A
Hikma Pharmaceuticals Plc
01 October 2020
Hikma Pharmaceuticals PLC
Block Listing Six Monthly Return
Date: 1 October 2020
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2004 Stock Option Plan ("SOP")
-------------------------------------------------------------
Period of return From: 1 April 2020 To: 30 September 2020
--------------------------- ----- -------------------------
Balance of unallotted securities under scheme(s) from SOP: 792,700 ordinary shares of 10 pence
previous return:
-------------------------------------------------------------
Plus: The amount by which the block scheme(s) has been SOP: 0 ordinary shares of 10 pence
increased since the date of the last
return (if any increase has been applied for):
-------------------------------------------------------------
Less: Number of securities issued/allotted under SOP: 0 ordinary shares of 10 pence
scheme(s) during period (see LR3.5.7G):
-------------------------------------------------------------
Equals: Balance under scheme(s) not yet SOP: 792,700 ordinary shares of 10 pence
issued/allotted at end of period:
-------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
Block Listing Six Monthly Return
Date: 1 October 2020
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2005 Long-Term Incentive Plan ("LTIP")
---------------------------------------------------------------------
Period of return From: 1 April 2020 To: 30 September 2020
------------------------------- ------ ----------------------------
Balance of unallotted securities under LTIP: 87,700 ordinary shares of 10 pence
scheme(s) from previous return:
---------------------------------------------------------------------
Plus: The amount by which the block scheme(s) LTIP: 0 ordinary shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
---------------------------------------------------------------------
Less: Number of securities issued/allotted LTIP: 30,198 ordinary shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
---------------------------------------------------------------------
Equals: Balance under scheme(s) not yet LTIP: 57,502 ordinary shares of 10 pence
issued/allotted at end of period:
---------------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
Block Listing Six Monthly Return
Date: 1 October 2020
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2009 Management Incentive Plan ("MIP")
---------------------------------------------------------------------
Period of return From: 1 April 2020 To: 30 September 2020
------------------------------- ------ ----------------------------
Balance of unallotted securities under MIP: 1,519,989 ordinary shares of 10 pence
scheme(s) from previous return:
---------------------------------------------------------------------
Plus: The amount by which the block scheme(s) MIP: 0 ordinary shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
---------------------------------------------------------------------
Less: Number of securities issued/allotted MIP: 380,293 ordinary shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
---------------------------------------------------------------------
Equals: Balance under scheme(s) not yet MIP: 1,139,696 ordinary shares of 10 pence
issued/allotted at end of period:
---------------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
Block Listing Six Monthly Return
Date: 1 October 2020
Name of applicant: Hikma Pharmaceuticals PLC
Name of scheme: Hikma Pharmaceuticals PLC 2014 Executive Incentive Plan ("EIP")
--------------------------------------------------------------------
Period of return From: 1 April 2020 To: 30 September 2020
------------------------------ ------ ----------------------------
Balance of unallotted securities under EIP: 1,102,558 ordinary shares of 10 pence
scheme(s) from previous return:
--------------------------------------------------------------------
Plus: The amount by which the block scheme(s) EIP: 0 ordinary shares of 10 pence
has been increased since the date of the last
return (if any increase has been applied for):
--------------------------------------------------------------------
Less: Number of securities issued/allotted EIP: 590,134 ordinary shares of 10 pence
under scheme(s) during period (see LR3.5.7G):
--------------------------------------------------------------------
Equals: Balance under scheme(s) not yet EIP: 512,424 ordinary shares of 10 pence
issued/allotted at end of period:
--------------------------------------------------------------------
Name of contact: Peter Speirs
Telephone number of contact: 0207 399 2772
--------------
LEI: 549300BNS685UXH4JI75
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BLRUPGUUUUPUGUG
(END) Dow Jones Newswires
October 01, 2020 06:01 ET (10:01 GMT)
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Sep 2024 to Oct 2024
Hikma Pharmaceuticals (LSE:HIK)
Historical Stock Chart
From Oct 2023 to Oct 2024